Related Experiment Videos
Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a
1Department of Clinical Pharmacology, St Bartholomew's Hospital, London.
Journal of the Royal Society of Medicine
|November 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Role of NF-kappa B in the regulation of inducible nitric oxide synthase in an MTAL cell line.
The American journal of physiology·1995
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis.
Lancet (London, England)·1995
Effect of ageing and propranolol administration on myocardial beta-adrenoceptor receptor function in mature rats.
European journal of pharmacology·1995
Identification of constitutive and inducible forms of nitric oxide synthase in human platelets.
The Journal of laboratory and clinical medicine·1995
Developing a new uniform policy for student nurses.
British journal of nursing (Mark Allen Publishing)·1992
Seven lessons for financial incentivisation schemes in healthcare: a qualitative study of NHS Resolution's Maternity Incentive Scheme.
Journal of the Royal Society of Medicine·2026
The historical development of sample size estimation: from Huygens and Bernoulli to the present.
Journal of the Royal Society of Medicine·2026
Alfred the Great: a diagnosis.
Journal of the Royal Society of Medicine·2026
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.
Journal of the Royal Society of Medicine·2026
Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.
Journal of the Royal Society of Medicine·2026
Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.
Journal of the Royal Society of Medicine·2026
Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.
Alimentary pharmacology & therapeutics·2026
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.
Expert opinion on drug delivery·2026
Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.
Perspectives in clinical research·2026
Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.
Current opinion in pediatrics·2026
Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.
Pharmaceuticals (Basel, Switzerland)·2026